BioCorRx Inc. (BICX) stock
BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
$0.25+0.00 (0.00%)
Close on Oct 19, 2026Market cap $7.30MP/E –Yield –
BioCorRx operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
BioCorRx's operating cash flow for the twelve months ending Jun 30, 2026 was -$2.36M. For fiscal 2025 it was -$2.30M. The highest annual figure on record is $167.67K in fiscal 2014.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.30M | – |
| FY2024 | Dec 31, 2024 | -$1.10M | – |
| FY2023 | Dec 31, 2023 | -$1.85M | – |
| FY2022 | Dec 31, 2022 | -$2.04M | – |
| FY2021 | Dec 31, 2021 | -$3.54M | – |
| FY2020 | Dec 31, 2020 | -$2.15M | – |
| FY2019 | Dec 31, 2019 | -$2.94M | – |
| FY2018 | Dec 31, 2018 | -$1.83M | – |
| FY2017 | Dec 31, 2017 | -$2.54M | – |
| FY2016 | Dec 31, 2016 | -$2.00M | -4277.7% |
| FY2015 | Dec 31, 2015 | $47.86K | -71.5% |
| FY2014 | Dec 31, 2014 | $167.67K | +62.1% |
| FY2013 | Dec 31, 2013 | $103.46K | – |
| FY2012 | Dec 31, 2012 | -$927.76K | – |
| FY2011 | Dec 31, 2011 | -$128.39K | – |
| FY2010 | Dec 31, 2010 | -$114.34K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$440.29K | – |
| Q1 FY2026 | Mar 31, 2026 | -$432.97K | – |
| Q4 FY2025 | Dec 31, 2025 | -$847.72K | – |
| Q3 FY2025 | Sep 30, 2025 | -$634.45K | – |
| Q2 FY2025 | Jun 30, 2025 | -$126.50K | – |
| Q1 FY2025 | Mar 31, 2025 | -$689.62K | – |
| Q4 FY2024 | Dec 31, 2024 | -$247.17K | – |
| Q3 FY2024 | Sep 30, 2024 | -$357.54K | – |
| Q2 FY2024 | Jun 30, 2024 | -$151.87K | – |
| Q1 FY2024 | Mar 31, 2024 | -$339.67K | – |
| Q4 FY2023 | Dec 31, 2023 | -$533.84K | – |
| Q3 FY2023 | Sep 30, 2023 | -$350.55K | – |
| Q2 FY2023 | Jun 30, 2023 | -$571.54K | – |
| Q1 FY2023 | Mar 31, 2023 | -$397.36K | – |
| Q1 FY2022 | Mar 31, 2022 | -$872.67K | – |
| Q2 FY2021 | Sep 30, 2021 | -$1.96M | – |
| Q1 FY2021 | Mar 31, 2021 | -$930.09K | – |
| Q4 FY2020 | Dec 31, 2020 | -$341.33K | – |
| Q3 FY2020 | Sep 30, 2020 | -$595.78K | – |
| Q2 FY2020 | Jun 30, 2020 | -$539.76K | – |
| Q1 FY2020 | Mar 31, 2020 | -$675.01K | – |
| Q4 FY2019 | Dec 31, 2019 | -$889.16K | – |
| Q3 FY2019 | Sep 30, 2019 | -$823.52K | – |
| Q2 FY2019 | Jun 30, 2019 | -$901.38K | – |
| Q1 FY2019 | Mar 31, 2019 | -$323.07K | – |
| Q4 FY2018 | Dec 31, 2018 | -$439.42K | – |
| Q3 FY2018 | Sep 30, 2018 | -$431.44K | – |
| Q2 FY2018 | Jun 30, 2018 | -$545.23K | – |
| Q1 FY2018 | Mar 31, 2018 | -$409.54K | – |
| Q4 FY2017 | Dec 31, 2017 | -$319.23K | – |
| Q3 FY2017 | Sep 30, 2017 | -$561.53K | – |
| Q2 FY2017 | Jun 30, 2017 | -$822.43K | – |
| Q1 FY2017 | Mar 31, 2017 | -$837.21K | – |
| Q4 FY2016 | Dec 31, 2016 | -$380.80K | -168.9% |
| Q3 FY2016 | Sep 30, 2016 | -$607.81K | – |
| Q2 FY2016 | Jun 30, 2016 | -$734.73K | – |
| Q1 FY2016 | Mar 31, 2016 | -$276.06K | – |
| Q4 FY2015 | Dec 31, 2015 | $552.39K | – |
See a number that looks wrong?